Use of information and communication technology in the support of viral hepatitis patients in Japan-Reference-Cited by-同舟云学术

Use of information and communication technology in the support of viral hepatitis patients in Japan

Published:2021-10-31 Issue:5 Volume:3 Page:314-320
ISSN:2434-9186
Container-title:Global Health & Medicine
language:en
Short-container-title:GHM

Author:

Shimakami Tetsuro¹,Kaneko Shuichi¹

Affiliation:

1. Department of Gastroenterology, Kanazawa University Hospital, Ishikawa, Japan.

Publisher

National Center for Global Health and Medicine (JST)

Link

https://www.jstage.jst.go.jp/article/ghm/3/5/3_2021.01061/_pdf

Reference8 articles.

1. 1. Tanaka J, Akita T, Ko K, Miura Y, Satake M; Epidemiological Research Group on Viral Hepatitis and its Long-term Course, Ministry of Health, Labour and Welfare of Japan. Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view. Hepatol Res. 2019; 49:990-1002.

2. 2. Tanaka J, Akita T, Ohisa M, Sakamune K, Ko K, Uchida S, Satake M. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011. J Viral Hepat. 2018; 25:363-372.

3. 3. Cancer Statistics. Cancer Information Service, National Cancer Center, Japan (Vital Statistics of Japan, Ministry of Health, Labour and Welfare). https://gdb.ganjoho.jp/graph_db/gdb1 (accessed June 24, 2021)

4. 4. Oza N, Isoda H, Ono T, Kanto T. Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation. Hepatol Res. 2017; 47:487-496.

5. 5. Kanto T, Yoshio S. Hepatitis action plan and changing trend of liver disease in Japan: viral hepatitis and nonalcoholic fatty liver disease. Euroasian J Hepatogastroenterol. 2017; 7:60-64

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher FIB-4 index at baseline predicts development of liver cancer in a community-based cohort with viral hepatitis;Global Health & Medicine;2024

2. Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan;Journal of Gastroenterology;2023-01-16